Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Overview

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Operating Income

Operating Income for DMAQR.

Quarterly Operating Income

$-1294579.00

↑ 4.89% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-6162709.00

↑ 157.48% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin